Hypothyroidism companies focus on providing medications and therapies for individuals with hypothyroidism, a condition characterized by an underactive thyroid gland. These companies contribute to endocrinology research by developing thyroid hormone replacement therapies to restore hormonal balance and manage symptoms associated with hypothyroidism.
Lupin Received US FDA approval for their Levothyroxine Sodium tablets, providing a generic alternative to Synthroid for treating hypothyroidism. Launched their Levothyroxine Sodium tablets in the US market, potentially increasing access and affordability for patients.
Abbott Laboratories Collaborated with the Federation of Obstetric and Gynaecological Societies of India (FOGSI) and Indian Thyroid Society (ITS) to raise awareness about the importance of thyroid screening in pregnant women. Focused on offering innovative thyroid diagnostic tests and promoting early detection of hypothyroidism.
Alvogen Iceland ehf Developed and commercialized Eltroxin (levothyroxine sodium tablets) in various strengths, offering another treatment option for patients with hypothyroidism. Investing in research on improved formulations and delivery systems for levothyroxine therapy.
Sandoz AG Launched their Levotyrox (levothyroxine sodium tablets) in various countries, further expanding their portfolio of thyroid medications. Implementing patient support programs and educational initiatives to improve medication adherence and disease management.
ThyroSense, Developed and commercialized the ThyroSpot test, a non-invasive, rapid saliva test for initial screening of hypothyroidism. Partnering with healthcare providers and organizations to integrate their innovative diagnostic tool into routine thyroid screening programs.
Hypothyroidism Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)